首页 iBio(usIBIO)-基本信息

iBio(usIBIO)-基本信息

日报更新时间:07-02 06:53

周报更新时间:01-23 11:54

行情信息

今开价:

最高价:

成交量:

昨收价:

最低价:

最新价:

行情图标
概要信息

英文名称:iBio


简介:iBio, Inc.于2008年8月注册成立。该公司是一家生物技术公司,专注于将其专有技术和产品商业化,并为客户和合作者提供产品开发和制造服务


电话:1-302-3550650


最新量化综合结论
百科信息
  • 相关网站
  • 员工交易记录
  • 持股信息
  • 领导人信息

交易日期 交易人 职位 类型 交易份额 价格
2018-07-11 EASTERN CAPITAL LTD Beneficial Owner of More than 10% Class Buy 2200000 0.90
2018-06-25 EASTERN CAPITAL LTD Beneficial Owner of More than 10% Class Buy 1683334 0.90
2017-11-29 EASTERN CAPITAL LTD Beneficial Owner of More than 10% Class Buy 12000000 0.20

机构持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
State Street Global Advisors 1002 0.01% -- -- 2019-07-31
TWO SIGMA SECURITIES, LLC 17223 0.09% 17223 -- 2019-03-31
BlackRock Inc 17404 0.09% 465 2.75% 2019-03-31
Virtu Financial LLC 17562 0.09% 6639 60.78% 2019-03-31
Vanguard Investments Australia Ltd 18358 0.09% -- -- 2019-07-31
Fidelity Management & Research Company 32629 0.17% -- -- 2019-07-31
Geode Capital Management, LLC 34266 0.17% -34266 -50.00% 2019-03-31
Citadel Advisors Llc 53241 0.27% 26656 100.27% 2019-03-31
Vanguard Group Inc 127915 0.65% 14953 13.24% 2019-03-31
Northern Trust Corp 14328 0.07% -- -- 2019-03-31
Northern Trust Investments N A 14328 0.07% -- -- 2019-03-31
Northern Trust Investments Inc 14187 0.07% 10 0.07% 2019-07-31
Morgan Stanley Smith Barney LLC 1450 0.01% -- -- 2019-03-31
Morgan Stanley - Brokerage Accounts 1450 0.01% -8 -0.55% 2019-03-31
Royal Bank of Canada 2009 0.01% -- -- 2019-03-31
USAA Asset Management Company 2101 0.01% -- -- 2019-07-31
BlackRock Fund Advisors 5938 0.03% -- -- 2019-07-31
BlackRock 7876 0.04% -11 -0.14% 2019-07-31
UBS Group AG 8645 0.04% -4612 -34.79% 2019-03-31
HighTower Advisors, LLC 10002 0.05% -- -- 2019-03-31
Mellon Investments Corporation 1745 0.01% -10351 -85.57% 2019-07-31
BlackRock Asset Management Canada Ltd 22874 0.12% 304 1.35% 2019-05-31
Panagora Asset Management Inc 932 -- -6919 -88.13% 2018-12-31
Fifth Third Bancorp 200 -- -- -- 2018-12-31
Bt Alex Brown Inc 27 -- 27 -- 2018-12-31
Deutsche Bank AG 27 -- 27 -- 2018-12-31
Patriot Financial Group Insurance Agency, LLC 100 -- 100 -- 2018-09-30
SignatureFD, LLC 15291 0.08% -137619 -90.00% 2018-09-30
Bank of America Corporation 2623 0.01% 2623 -- 2018-09-30
Vanguard 2960 0.02% 2960 -- 2018-11-30
UBS Securities LLC 9048 0.05% -8598 -48.72% 2018-06-30
BlackRock Institutional Trust Company NA 12040 0.06% -- -- 2018-06-30
BNY Mellon Asset Management North America Corporation 19122 0.10% 13825 261.00% 2018-11-30
Bank of New York Mellon Corp 90478 0.49% 16613 22.49% 2018-03-31
BNY Mellon Investment Management 69463 0.37% -- -- 2018-03-31
Susquehanna International Group, LLP 50874 0.27% 50874 -- 2018-03-31
United Services Automobile Association 21015 0.11% 21015 -- 2018-03-31
Susquehanna Financial Group, LLLP 50874 0.27% 50874 -- 2018-03-31
State Street Corporation 12000 0.06% -- -- 2018-03-31
Mellon Capital Management Corporation 5941 0.04% -- -- 2018-06-30
Eastern Capital LTD 8498512 48.72% -435000 -4.87% 2018-07-12
Vanguard Group Inc. 984 0.01% -1 -0.10% 2018-06-30
Parallel Advisors, LLC 925 0.01% -- -- 2017-12-31
Merrill Lynch & Co Inc 4000 0.04% -- -- 2018-03-31
United Asset Strategies Inc 10000 0.08% -- -- 2018-03-31
State Street Corp 12000 0.08% -- -- 2018-03-31
BlackRock Advisors LLC 21015 0.02% -- -- 2018-01-31
Aveo Capital Partners, LLC 72200 0.08% -- -- 2017-09-30
KCG AMERICAS LLC 17757 0.02% -75320 -80.92% 2017-06-30
Arcus Capital Partners LLC 3107006 3.49% 3107006 -- 2016-09-30
Jnba Financial Advisors Inc 152910 0.17% 152910 -- 2016-09-30
Raymond James & Associates 50000 0.06% -- -- 2016-09-30
Ayalon Mutual Funds Ltd. 17000 0.02% -- -- 2016-11-30
Carl DeSantis 5014873 10.00% 3410615 0.10% 1999-11-30
E. Gerald Kay 5945695 10.00% 4043667 0.10% 1999-11-30
Eastern Capital Limited 21960000 10.00% 14934996 0.30% 1999-11-30
共同基金持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
BNYM Mellon NSL Mkt Completion Fd Instl -- -- -5948 -100.00% 2019-06-30
Fidelity 2960 0.02% -- -- 2019-06-30
iShares Core S&P Total US Stock Mkt ETF 5938 0.03% -- -- 2019-07-30
Vanguard Balanced Index Fund 7387 0.04% -- -- 2019-06-30
BlackRock Extended Equity Market 7876 0.04% -11 -0.14% 2019-06-30
NT Ext Equity Market Index Fund - L 13861 0.07% -- -- 2019-06-30
Vanguard Total Stock Market Index Fund 18358 0.09% -- -- 2019-06-30
Vanguard Extended Market Index Fund 87761 0.45% -- -- 2019-06-30
Vanguard Instl Total Stock Market Idx Fd 18910 0.10% -- -- 2019-06-30
USAA Extended Market Index Fund 2101 0.01% -- -- 2019-06-30
State Street U.S. Extended Market Index 1002 0.01% -- -- 2019-06-30
BNYM Mellon SL Mkt Completion Fd -- -- -1745 -100.00% 2019-06-30
iShares Core MSCI AllCntry Wld exCan ETF 3 -- -- -- 2019-07-30
iShares Core S&P US Total Mkt ETF CADH 7 -- -- -- 2019-07-22
iShares Core Balanced ETF Portfolio 9 -- -- -- 2019-07-30
iShares Core Growth ETF Portfolio 14 -- -- -- 2019-07-30
iShares Core S&P US Total Market ETF 105 -- -- -- 2019-07-30
NT Ext Equity Mkt Fd - DC - NL 136 -- 10 7.94% 2019-06-30
NT Extended Equity Market Idx Fund - NL 190 -- -- -- 2019-06-30
NT Ext Equity Mkt Idx Fd - DC - NL 136 -- 10 7.94% 2019-06-30
The Vanguard Total Stock Market Index -- -- -2960 -100.00% 2018-07-31
Vanguard US Equity Index Fund -- -- -984 -100.00% 2018-12-31
BNYM Mellon SL Market Completion Fund 1745 0.01% -4403 -71.62% 2019-03-31
BNY Mellon Market Completion Fund 523 -- -1389 -72.65% 2018-12-31
Master Extended Market Index Series -- -- -21015 -100.00% 2018-02-28
Vanguard Total Stock Mkt Idx 62933 0.36% -- -- 2018-07-31
Vanguard Instl Ttl Stk Mkt Idx InstlPls 17710 0.10% -- -- 2018-07-31
BlackRock Extended Equity Market K 7822 0.05% 213 2.80% 2018-06-30
Vanguard Balanced Index Inv 7191 0.04% -- -- 2018-07-31
iShares Core S&P Total US Stock Mkt 4275 0.03% -- -- 2018-09-12
BNY Mellon EB DL Mkt Completion 5941 0.04% -- -- 2018-06-30
Fidelity Spartan 4036 0.02% -- -- 2018-07-31
USAA Extended Market Index 2101 0.01% -- -- 2018-07-31
Vanguard Extended Market Idx Inv 87762 0.50% 100 0.11% 2018-07-31
SSgA U.S. Total Market Index Fd Class I 2797 0.02% -183 -6.14% 2017-12-31
BNY Mellon Market Completion Fund UC1 19122 0.16% 13825 261.00% 2018-03-31
BlackRock LifePath 91 -- 32 54.24% 2016-03-31
Vanguard Instl Total Stock Market Index 177100 0.20% -- -- 2015-10-31
Mellon Capital EB DL Mkt Completion Fund 75373 0.10% -- -- 2015-09-30
BlackRock Extended Equity Market Fund 74199 0.10% -149 -0.20% 2015-09-30
Fidelity Spartan® Total Market Idx Fund 40361 -- -- -- 2015-09-30
The Vanguard - Total Stk Mkt Idx Trust. CF 29600 -- -- -- 2015-09-30
Diamond Equity 17000 -- -- -- 2015-08-31
Vanguard US Equity Index 9846 -- -- -- 2015-07-31
BlackRock LifePath® Index 2060 Fund 30 -- 30 -- 2015-06-30
Fidelity Spartan® Extended Mkt Indx Fd 302306 0.40% -- -- 2015-09-30

John D. McKey John D. McKey is on the board of iBio, Inc. and Of Counsel at McCarthy, Summers, Bobko, Wood & Sawyer PA. In the past Mr. McKey held the position of Partner at Gunster, Yoakley & Stewart PA. He received an undergraduate degree from the University of Georgia and a graduate degree from Florida College.
Seymour Flug Seymour Flug is on the board of iBio, Inc. In his past career Mr. Flug occupied the position of Chairman & Chief Executive Officer of Diners Club International Ltd., Senior Vice President of Hess Oil Co., Inc. and Managing Director at Citibank, NA (New York). Mr. Flug received an undergraduate degree from Baruch College.
Robert B. Kay Robert B. Kay founded Kay Collyer & Boose LLP. Presently, Mr. Kay holds the position of Chairman & Principal at Seaway Biltmore, Inc., Executive Chairman & Chief Executive Officer of iBio, Inc. and Chairman of InB:Paxis Pharmaceuticals, Inc. Mr. Kay is also Manager at EVJ LLC and Principal at Seaway Hotels Corp. In the past Robert B. Kay occupied the position of Senior Partner at Kay Collyer & Boose LLP. He received a graduate degree from New York University School of Law and an undergraduate degree from Cornell University College of Arts & Sciences.
Robert L. Erwin Robert L. Erwin is a businessperson who founded Marti Nelson Cancer Foundation and who has been at the head of 5 different companies. He holds the position of Chairman for Novici Biotech LLC and President for iBio, Inc. Mr. Erwin is also on the board of Expanesthetics, Inc. and Oryn Therapeutics LLC and President & Director at Marti Nelson Cancer Foundation, Member-Cancer Policy Forum at Institute of Medicine and Member-Research Committee at American Society of Clinical Oncology. In the past Robert L. Erwin held the position of Non-Executive Chairman for Large Scale Biology Corp., Managing Director at Bio-Strategic Directors LLC and Chairman for Icon Genetics GmbH. Mr. Erwin received an undergraduate degree and a graduate degree from Louisiana State University.
Glenn J. Chang Presently, Glenn J. Chang occupies the position of Chief Financial Officer at Singer Vehicle Design and Chief Financial Officer at State Bank of Missouri (Concordia). Mr. Chang is also on the board of iBio, Inc. In his past career Mr. Chang held the position of Chief Financial Officer at Alma Bank (New York), Chief Financial Officer & Executive Vice President of First American International Bank (New York) and Vice President for Citibank, NA (New York).
James Thomas Hill Currently, James Thomas Hill holds the position of President at JT Hill Group, Inc. Mr. Hill is also on the board of iBio, Inc.
Philip K. Russell Dr. Philip K. Russell, MD, is an Independent Director at iBio, Inc. and a Director-Emeritus at International AIDS Vaccine Initiative, Inc. He is on the Board of Directors at iBio, Inc. and Walter Reed Army Institute of Research. Dr. Russell was previously employed as a Major General by The United States Army Medical Service Corps, a Commander by US Army Medical Research Committee, a Trustee by Albert B. Sabin Vaccine Institute, Inc., and a Professor by Johns Hopkins Bloomberg School of Public Health. He also served on the board at Aeras Global TB Vaccine Foundation, International Vaccine Institute and PaxVax, Inc.
Philip K. Russell Dr. Philip K. Russell, MD, is an Independent Director at iBio, Inc. and a Director-Emeritus at International AIDS Vaccine Initiative, Inc. He is on the Board of Directors at iBio, Inc. and Walter Reed Army Institute of Research. Dr. Russell was previously employed as a Major General by The United States Army Medical Service Corps, a Commander by US Army Medical Research Committee, a Trustee by Albert B. Sabin Vaccine Institute, Inc., and a Professor by Johns Hopkins Bloomberg School of Public Health. He also served on the board at Aeras Global TB Vaccine Foundation, International Vaccine Institute and PaxVax, Inc.
Douglas C. Hicks Douglas C. Hicks is Senior VP-Business Development & Strategy at iBio, Inc. He received an MBA from The Pennsylvania State University.
Terence E. Ryan Terence E. Ryan is Chief Scientific Officer at iBio, Inc. In his past career Dr. Ryan held the position of Associate Director-Cell Technologies at Regeneron Pharmaceuticals, Inc., Assistant Vice President at Pfizer Inc., Director-Cell Biology at Celera Group and Director-Integrative Biology at GlaxoSmithKline LLC. Dr. Ryan received an undergraduate degree from Princeton University and a doctorate and a graduate degree from Rutgers State University of New Jersey.
James P. Mullaney Presently, James P. Mullaney occupies the position of CFO & Principal Accounting Officer of iBio, Inc. In his past career Mr. Mullaney occupied the position of Corporate Controller at Citihub Consulting.
James Abbey James Abbey is Vice President-Strategic Business Development at iBio, Inc. He received a doctorate from Swansea University, an MBA from The University of Wales and an undergraduate degree from the University of North Texas.
Thomas F. Isett Currently, Thomas F. Isett occupies the position of Chief Executive Officer for Transposagen Biopharmaceuticals, Inc. He is also on the board of iBio, Inc.

量化对比

全部评论 7

  • 【疫苗股普遍下跌,血浆类股涨跌各异】疫苗股里,Alpha Pro Tech收跌将近5.5%,Vaxart跌约3.8%,诺瓦瓦克斯跌超2.5%,辉瑞制药跌约1.6%,阿斯利康跌超1.4%,Moderna跌超1.2%,Inovio Pharmaceuticals则涨超3.9%,辉瑞合作伙伴BioNTech也涨超6.0%。血浆类股里,Thermogenesis Holdings收跌逾10.6%,iBio跌超3.8%,T2 Biosystems跌超3%,Liminal BioSciences则涨约1.9%,Cerus也涨超1.7%。

  • 美股抗疫概念股逆市走高。Co-Diagnostics涨超12%,Vaxart涨5.3%,iBio涨4.3%,雷克兰医疗工业涨超3%。

  • 美股抗疫概念股盘前走强,iBio涨超19%,Vaxart涨超13%,Inovio涨超9%,诺瓦瓦克斯医药涨近5%。

  • 美股抗疫概念股盘前走强,iBio涨超19%,Vaxart涨超13%,Inovio涨超9%,诺瓦瓦克斯医药涨近5%。

  • 【疫苗股和血浆类股均普遍下跌】疫苗股Alpha Pro Tech跌超10%,诺瓦瓦克斯跌超9%,Inovio跌约6.0%,Moderna跌约2.3%,辉瑞制药跌约0.7%、其德国合作伙伴BioNTech也跌4.8%,阿斯利康则涨0.4%。血浆股iBio跌约10.6%,Thermogenesis跌约9.0%,Sonnet Biotherapeutics和Cancer Genetics均跌超6.5%,Liminal BioSciences和Cerus至少跌超5.6%。

  • 【疫苗股和血浆类股均普遍下跌】疫苗股Alpha Pro Tech跌超10%,诺瓦瓦克斯跌超9%,Inovio跌约6.0%,Moderna跌约2.3%,辉瑞制药跌约0.7%、其德国合作伙伴BioNTech也跌4.8%,阿斯利康则涨0.4%。血浆股iBio跌约10.6%,Thermogenesis跌约9.0%,Sonnet Biotherapeutics和Cancer Genetics均跌超6.5%,Liminal BioSciences和Cerus至少跌超5.6%。

  • 美股多只生物制药概念个股大涨,Cancer Genetics(CGIX.O)涨近150%,iBio(IBIO.O)涨45%,Sonnet BioTherapeutics(SONN.O)涨近50%,ADMA生物(ADMA.O)涨17.3%。日前美国药监局向血浆疗法授予使用紧急授权(EUA),治疗医院收治的新冠肺炎病人。

阿布量化公众号二维码 abu_quant 扫一扫关注阿布量化

热门推荐